INBX
Morgan Stanley’s Inhibrx, Inc. Common Stock INBX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-549,469
| Closed | -$19.2M | – | 8106 |
|
|
2024
Q1 | $19.2M | Sell |
549,469
-44,369
| -7% | -$1.55M | ﹤0.01% | 2744 |
|
|
2023
Q4 | $22.6M | Buy |
593,838
+211,068
| +55% | +$8.02M | ﹤0.01% | 3226 |
|
|
2023
Q3 | $7.02M | Sell |
382,770
-1,885
| -0.5% | -$34.6K | ﹤0.01% | 3443 |
|
|
2023
Q2 | $9.99M | Buy |
384,655
+8,435
| +2% | +$219K | ﹤0.01% | 3163 |
|
|
2023
Q1 | $7.1M | Buy |
376,220
+119,202
| +46% | +$2.25M | ﹤0.01% | 3467 |
|
|
2022
Q4 | $6.33M | Buy |
257,018
+95,985
| +60% | +$2.37M | ﹤0.01% | 3532 |
|
|
2022
Q3 | $2.89M | Buy |
161,033
+20,682
| +15% | +$371K | ﹤0.01% | 4159 |
|
|
2022
Q2 | $1.59M | Sell |
140,351
-144,068
| -51% | -$1.63M | ﹤0.01% | 4701 |
|
|
2022
Q1 | $6.34M | Buy |
284,419
+228,052
| +405% | +$5.08M | ﹤0.01% | 3426 |
|
|
2021
Q4 | $2.46M | Buy |
56,367
+53,099
| +1,625% | +$2.32M | ﹤0.01% | 4410 |
|
|
2021
Q3 | $108K | Sell |
3,268
-23,066
| -88% | -$762K | ﹤0.01% | 6327 |
|
|
2021
Q2 | $724K | Sell |
26,334
-8,894
| -25% | -$245K | ﹤0.01% | 5279 |
|
|
2021
Q1 | $707K | Buy |
35,228
+29,061
| +471% | +$583K | ﹤0.01% | 4949 |
|
|
2020
Q4 | $203K | Buy |
+6,167
| New | +$203K | ﹤0.01% | 5585 |
|